A detailed history of Jackson Creek Investment Advisors LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 91,070 shares of ADMA stock, worth $1.84 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
91,070
Previous 120,782 24.6%
Holding current value
$1.84 Million
Previous $1.35 Million 34.81%
% of portfolio
0.54%
Previous 0.49%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$11.21 - $20.03 $333,071 - $595,131
-29,712 Reduced 24.6%
91,070 $1.82 Million
Q2 2024

Aug 01, 2024

SELL
$5.98 - $11.18 $473,185 - $884,651
-79,128 Reduced 39.58%
120,782 $1.35 Million
Q1 2024

May 09, 2024

BUY
$4.4 - $6.74 $879,604 - $1.35 Million
199,910 New
199,910 $1.32 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.97B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.